What is CVE-2022-48226?

CVE-2022-48226 is a high-severity vulnerability in Gbgplc Acuant Acufill Sdk, classified under Improper Privilege Management. CVSS score: 7.8/10. Published 2023-04-04.

How severe is CVE-2022-48226?

High severity. CVSS v3 base score is 7.8 out of 10.

Privilege escalation in Gbgplc Acuant Acufill Sdk

CVE-2022-48226

An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During installation, an EXE gets executed out of C:\Windows\Temp. A standard user can create the path file ahead of time and obtain elevated code execution. Permissions need to be modified to prevent manipulation.

Vulnerability class: Privilege Escalation

EPSS: 0.002 (8.1th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 7.8 (High). Vector: CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H.

Affected products

Gbgplc Acuant_acufill_sdk
N/a — versions n/a

Weakness classification (CWE)

CWE-269 — Improper Privilege Management

References

cve@mitre.org (Not Applicable)
cve@mitre.org (Third Party Advisory)

Frequently asked questions

What is CVE-2022-48226?: CVE-2022-48226 is a high-severity vulnerability in Gbgplc Acuant Acufill Sdk, classified under Improper Privilege Management. CVSS score: 7.8/10. Published 2023-04-04.
How severe is CVE-2022-48226?: High severity. CVSS v3 base score is 7.8 out of 10.